Skip Navigation

Faculty Directory

Patrick M. Tarwater, PhD

  • Professor - Adjunct

Departmental Affiliations

Contact Information

4801 Alberta Avenue
Room A3600
EL Paso, Texas 79905


View Current Courses


PhD, The University of Texas Health Science Center at Houston, 1999
MS, Texas Tech University, 1992


From 1999 to 2002, Dr. Tarwater was an assistant research professor at the Bloomberg School of Public Health. Dr. Tarwater's research included bivariate processes and nonlinear models for characterization of trajectories of immunologic markers after treatment in HIV-studies, the comparison of methods to determine the effectiveness of antiretroviral therapies at the population level in HIV-1 incident and prevalent cohorts, the impact of antiretroviral therapy on the trajectories of immunologic and virologic markers of disease progression, and longitudinal assesments of HIV prgrerssion markers among those who discontinued HARRT. Dr. Tarwater collaborated closely with investigators of the Multicenter AIDS Cohort Study (MACS) and the Women's Interagency HIV Study (WIHS). Current collaborations with the Retrovirus Labortatory within the Department of Comparative Medicine at the Hopkins School of Medicine have focused on research identifying the neuropathy of HIV disease and treatments via SIV macaque model of HIV progression.

  • Biostatistics Epidemiology Survival Analysis Longitudinal Data Analysis HIV/AIDS
  • Detels R, Tarwater PM, Phair JP, Margolick J, Riddler SA, and Munoz A. Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis. AIDS 2001; 15:347-355.

  • Tarwater PM, Margolick J, Jin J, Phair J, Detels R, Rinaldo C, Giorgi J, and Muñoz A. Increase and plateau of CD4 T cell counts in the 3 ½ years following initiation of potent antiretroviral therapy. J Acquir Immune Defic Syndr 2001;27:168-75

  • Sacktor N, Tarwater PM, Skolasky MA, McArthur JC, Selnes A, Becker J, Cohen B, Miller EN. CSF antiretroviral drug penetrance and the treatment of HIV-associated psychomotor slowing. Neurology 2001; 57:542-5.

  • Tarwater PM, Mellors J, Gore ME, Margolick J, Phair J, Detels R, and Muñoz A Methods to assess population effectiveness of therapies in HIV incident and prevalent cohorts. Am J Epidemiol 2001; 154:675-81.

  • Babas T, Vieler E, Hauer DA, Adams RJ, Tarwater PM, Fox KJ, Clements JE, and Zink MC. Pathogenesis of SIV pneumonia: selective replication of viral genotypes in the lung. Virology 2001; 2:371-81.